CN106620659A - 一种有助于骨健康的食品组合物 - Google Patents
一种有助于骨健康的食品组合物 Download PDFInfo
- Publication number
- CN106620659A CN106620659A CN201611174946.5A CN201611174946A CN106620659A CN 106620659 A CN106620659 A CN 106620659A CN 201611174946 A CN201611174946 A CN 201611174946A CN 106620659 A CN106620659 A CN 106620659A
- Authority
- CN
- China
- Prior art keywords
- parts
- bone
- joint
- prevented
- food composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 235000013305 food Nutrition 0.000 title claims abstract description 23
- 230000037180 bone health Effects 0.000 title claims abstract description 14
- 230000009286 beneficial effect Effects 0.000 title abstract 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical class C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 23
- 241000561734 Celosia cristata Species 0.000 claims abstract description 13
- 102000000503 Collagen Type II Human genes 0.000 claims abstract description 13
- 108010041390 Collagen Type II Proteins 0.000 claims abstract description 13
- 210000001520 comb Anatomy 0.000 claims abstract description 13
- 235000012754 curcumin Nutrition 0.000 claims abstract description 11
- 229940109262 curcumin Drugs 0.000 claims abstract description 11
- 239000004148 curcumin Substances 0.000 claims abstract description 11
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims abstract description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 claims description 11
- 230000004913 activation Effects 0.000 claims description 10
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 8
- 235000003373 curcuma longa Nutrition 0.000 claims description 8
- 235000013976 turmeric Nutrition 0.000 claims description 8
- 244000163122 Curcuma domestica Species 0.000 claims description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 7
- 229920002774 Maltodextrin Polymers 0.000 claims description 7
- 239000005913 Maltodextrin Substances 0.000 claims description 7
- 229930003268 Vitamin C Natural products 0.000 claims description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 7
- 229940035034 maltodextrin Drugs 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 235000019154 vitamin C Nutrition 0.000 claims description 7
- 239000011718 vitamin C Substances 0.000 claims description 7
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 3
- 244000008991 Curcuma longa Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 208000006820 Arthralgia Diseases 0.000 abstract description 5
- 210000000988 bone and bone Anatomy 0.000 abstract description 5
- 208000001132 Osteoporosis Diseases 0.000 abstract description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 206010061363 Skeletal injury Diseases 0.000 abstract description 3
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 3
- 206010003246 arthritis Diseases 0.000 abstract description 3
- 229910052791 calcium Inorganic materials 0.000 abstract description 3
- 239000011575 calcium Substances 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 208000010392 Bone Fractures Diseases 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 210000000845 cartilage Anatomy 0.000 abstract description 2
- 238000006731 degradation reaction Methods 0.000 abstract description 2
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 2
- 230000008376 long-term health Effects 0.000 abstract description 2
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 abstract 2
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 abstract 2
- 235000019143 vitamin K2 Nutrition 0.000 abstract 2
- 239000011728 vitamin K2 Substances 0.000 abstract 2
- 206010017076 Fracture Diseases 0.000 abstract 1
- 208000008558 Osteophyte Diseases 0.000 abstract 1
- 230000002308 calcification Effects 0.000 abstract 1
- 239000003973 paint Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 5
- 239000012467 final product Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 150000005846 sugar alcohols Chemical class 0.000 description 3
- 208000032170 Congenital Abnormalities Diseases 0.000 description 2
- 241000750004 Nestor meridionalis Species 0.000 description 2
- 210000001188 articular cartilage Anatomy 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000001009 osteoporotic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000005065 subchondral bone plate Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明提供了一种有助于骨健康的食品组合物，其特征在于，按照重量份数，包括如下成分：鸡冠提取物1‑5份；非变性二型胶原蛋白1‑3份；维生素K2 1‑3份；微活化姜黄素5‑10份。本发明的组合物具有如下技术效果：1）增加关节滑液，弥补滑液流失造成的关节磨损、骨刺等骨损伤；2）添加抗炎分子，缓解关节炎疼痛，降低软骨的降解反应，促进骨关节的长期健康；3）预防骨质疏松，降低骨折风险，构建坚强的骨骼网络；降低血钙浓度，防止心血管钙化。4）鸡冠提取物、非变性二型胶原蛋白、姜黄素的联合使用，在补充关节滑液的同时抑制炎症反应，可以缓解关节疼痛；维生素K2的加入可以预防中老年人的骨质疏松的发生。
Description
技术领域
本发明涉及一种有助于骨健康的食品组合物，属于食品领域。
背景技术
退行性关节炎是一种退行性病变，由于增龄、肥胖、劳损、创伤、关节先天性异常、关节畸形等诸多因素引起的关节软骨退化损伤、关节边缘和软骨下骨反应性增生。患者多见于中老年人群，好发于负重关节及活动量较多的关节(如，颈椎、腰椎、膝关节、髋关节等)。目前市场上针对此类患者的主要产品为硫酸软骨素，但该产品质量参差不齐且吸收率比较低，疗效有限，而一些药物则具有强烈的副作用。
发明内容
本发明的目的是克服现有技术的不足，提供一种有助于骨健康的食品组合物
本发明的有助于骨健康的食品组合物，按照重量份数，包括如下成分：鸡冠提取物1-5份；非变性二型胶原蛋白1-3份；维生素K2 1-3份；微活化姜黄素5-10份。
优选地，
所述的有助于骨健康的食品组合物，按照重量份数，包括以下成分：鸡冠提取物1-5份；非变性二型胶原蛋白1-3份；维生素K2 1-3份；微活化姜黄素5-10份；麦芽糊精 55-65份；赤藓糖醇 45-55份；水果粉45-55份；姜黄提取物5-10份；食用香精20-25份；维生素C 1-5份。
所述的有助于骨健康的食品组合物，按照重量份数，包括以下成分：鸡冠提取物4份；非变性二型胶原蛋白2份；维生素K2 1.5份；微活化姜黄素7.5份；麦芽糊精 60份；赤藓糖醇50份；水果粉50份；姜黄提取物7.5份；食用香精22份；维生素C 3份。
本发明的食品组合物的制备方法：按照重量比例称量各个原料成分，烘干，混合均匀灌装即得。
本发明中，各个组分功能如下：
1）鸡冠提取物，用于增加关节滑液，弥补滑液流失造成的关节磨损等骨损伤，如含量过高增加成本，如含量过低达不到效果；
2）非变性二型胶原蛋白，减缓关节疼痛与发炎，停止关节软骨遭侵蚀，修复及重建软骨，改善关节灵活性，如含量过高增加成本，如含量过低达不到效果；
3）维生素K2，用于治疗和预防骨质疏松症；如含量过高增加成本，如含量过低达不到效果；
4）微活化姜黄素，抗发炎，抗氧化作用，如含量过高增加成本，如含量过低达不到效果；
本发明的组合物具有如下技术效果：
1）增加关节滑液，弥补滑液流失造成的关节磨损、骨刺等骨损伤；
2）添加抗炎分子，缓解关节炎疼痛，降低软骨的降解反应，促进骨关节的长期健康；
3）预防骨质疏松，降低骨折风险，构建坚强的骨骼网络；降低血钙浓度，防止心血管钙化。
4）鸡冠提取物、非变性二型胶原蛋白、姜黄素的联合使用，在补充关节滑液的同时抑制炎症反应，可以缓解关节疼痛；维生素K2的加入可以预防中老年人的骨质疏松的发生。
具体实施方式
本发明中，各成分均购自中国台湾创百股份有限公司。
实施例1
本发明的有助于骨健康的食品组合物，按照重量份数由以下成分组成：鸡冠提取物1份；非变性二型胶原蛋白1份；维生素K2 3份；微活化姜黄素5份；麦芽糊精 65份；赤藓糖醇55份；水果粉 55份；姜黄提取物 10份；食用香精25份；维生素C 1份。
本发明的食品组合物的制备方法：按照重量比例称量各个原料成分，烘干，混合均匀灌装即得，每袋2g。
服用方法：泡水饮用，一天两次，每次一袋。
实施例2
本发明的有助于骨健康的食品组合物，按照重量份数由以下成分组成：鸡冠提取物 5份；非变性二型胶原蛋白3份；维生素K2 1份；微活化姜黄素10份；麦芽糊精 55 份；赤藓糖醇 45份；水果粉45份；姜黄提取物5份；食用香精20份；维生素C 5份。
本发明的食品组合物的制备方法：按照重量比例称量各个原料成分，烘干，混合均匀灌装即得，每袋2g。
服用方法：泡水饮用，一天两次，每次一袋。
实施例3
本发明的有助于骨健康的食品组合物，按照重量份数由以下成分组成：鸡冠提取物4份；非变性二型胶原蛋白2份；维生素K2 1.5份；微活化姜黄素7.5份；麦芽糊精 60份；赤藓糖醇50份；水果粉50份；姜黄提取物7.5份；食用香精22份；维生素C 3份。
本发明的食品组合物的制备方法：按照重量比例称量各个原料成分，烘干，混合均匀灌装即得，每袋2g。
服用方法：泡水饮用，一天两次，每次一袋。
实施例4
实施例3的食品组合物的食用效果如下：
案例1：孙某，男，59岁，患有关节炎、骨刺等症状，脚踝、膝盖关节磨损严重，行走疼痛，服用过硫酸软骨素，但基本无效。服用本产品3个月后，走动时不会有咔咔声发出，且不再疼痛，阴天时关节不适减轻。
案例2：徐某，女，50岁，患有退行性关节炎伴骨质疏松，关节隐隐疼痛，走楼梯时疼痛明显，骨关节常伴有摩擦声。服用本产品3个月后，关节疼痛基本消失，可以正常上下楼梯，且走路无关节摩擦声。
案例3：陈某，女，52岁，走路时伴有关节不适感，蹲下起来时关节有咔咔声，但无明显疼痛。服用本品3个月后，关节不适感消失，关节摩擦声消失。
实施例1和实施例2的食用效果与实施例3近似。
Claims (3)
1.一种有助于骨健康的食品组合物，其特征在于，按照重量份数，包括如下成分：鸡冠提取物1-5份；非变性二型胶原蛋白1-3份；维生素K2 1-3份；微活化姜黄素5-10份。
2.根据权利要求1所述的有助于骨健康的食品组合物，其特征在于，按照重量份数，包括以下成分：鸡冠提取物1-5份；非变性二型胶原蛋白1-3份；维生素K2 1-3份；微活化姜黄素5-10份；麦芽糊精 55-65份；赤藓糖醇 45-55份；水果粉45-55份；姜黄提取物5-10份；食用香精20-25份；维生素C 1-5份。
3.根据权利要求2所述的有助于骨健康的食品组合物，其特征在于，按照重量份数，包括以下成分：鸡冠提取物4份；非变性二型胶原蛋白2份；维生素K2 1.5份；微活化姜黄素7.5份；麦芽糊精 60份；赤藓糖醇50份；水果粉50份；姜黄提取物7.5份；食用香精22份；维生素C3份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611174946.5A CN106620659A (zh) | 2016-12-19 | 2016-12-19 | 一种有助于骨健康的食品组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611174946.5A CN106620659A (zh) | 2016-12-19 | 2016-12-19 | 一种有助于骨健康的食品组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106620659A true CN106620659A (zh) | 2017-05-10 |
Family
ID=58822968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611174946.5A Pending CN106620659A (zh) | 2016-12-19 | 2016-12-19 | 一种有助于骨健康的食品组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106620659A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107373675A (zh) * | 2017-07-20 | 2017-11-24 | 钟祥亿源生物科技有限公司 | 一种保护骨关节组合物 |
| CN109106944A (zh) * | 2018-10-10 | 2019-01-01 | 安徽盛美诺生物技术有限公司 | 一种预防和治疗骨关节炎的组合物及其应用 |
| CN109567157A (zh) * | 2018-10-23 | 2019-04-05 | 北京同仁堂健康药业股份有限公司 | 一种用于改善骨关节健康的组合物及其制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2736914A1 (en) * | 2008-10-02 | 2010-04-08 | Guy Chamberland | Compositions comprising plant extracts and use thereof for treating inflammation |
| CN101711161A (zh) * | 2007-03-19 | 2010-05-19 | 麦特普罗泰欧米克斯有限公司 | 促进骨骼和关节健康的方法及组合物 |
| CN102423487A (zh) * | 2011-12-23 | 2012-04-25 | 内蒙古伊利实业集团股份有限公司 | 一种骨关节保健组合物及其应用 |
| CN102511604A (zh) * | 2011-12-21 | 2012-06-27 | 广东仙乐制药有限公司 | 一种富含胶原蛋白的无糖型软糖及其制备方法 |
| CN102698254A (zh) * | 2012-06-05 | 2012-10-03 | 哈尔滨珍宝制药有限公司 | 一种增加骨密度的组合物，含其制剂及其制备方法 |
-
2016
- 2016-12-19 CN CN201611174946.5A patent/CN106620659A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101711161A (zh) * | 2007-03-19 | 2010-05-19 | 麦特普罗泰欧米克斯有限公司 | 促进骨骼和关节健康的方法及组合物 |
| CA2736914A1 (en) * | 2008-10-02 | 2010-04-08 | Guy Chamberland | Compositions comprising plant extracts and use thereof for treating inflammation |
| CN102511604A (zh) * | 2011-12-21 | 2012-06-27 | 广东仙乐制药有限公司 | 一种富含胶原蛋白的无糖型软糖及其制备方法 |
| CN102423487A (zh) * | 2011-12-23 | 2012-04-25 | 内蒙古伊利实业集团股份有限公司 | 一种骨关节保健组合物及其应用 |
| CN102698254A (zh) * | 2012-06-05 | 2012-10-03 | 哈尔滨珍宝制药有限公司 | 一种增加骨密度的组合物，含其制剂及其制备方法 |
Non-Patent Citations (4)
| Title |
|---|
| 尤新: ""国内外天然功能性食品添加剂开发动向"", 《精细与专用化学品》 * |
| 徐丽萍 等: ""鸡冠中透明质酸提取工艺条件的研究"", 《哈尔滨商业大学学报（自然科学版）》 * |
| 李树壮: "维生素K2创造生命"奇迹"", 《维生素K2 维护骨骼和血管健康的革命性贡献》 * |
| 迈克尔·默里: "姜黄素", 《关节炎》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107373675A (zh) * | 2017-07-20 | 2017-11-24 | 钟祥亿源生物科技有限公司 | 一种保护骨关节组合物 |
| CN109106944A (zh) * | 2018-10-10 | 2019-01-01 | 安徽盛美诺生物技术有限公司 | 一种预防和治疗骨关节炎的组合物及其应用 |
| CN109106944B (zh) * | 2018-10-10 | 2021-12-07 | 北京盛美诺生物技术有限公司 | 一种预防和治疗骨关节炎的组合物及其应用 |
| CN109567157A (zh) * | 2018-10-23 | 2019-04-05 | 北京同仁堂健康药业股份有限公司 | 一种用于改善骨关节健康的组合物及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chan et al. | Assessment and treatment of children with cerebral palsy | |
| Liu et al. | Double-column fixation for type C fractures of the distal humerus in the elderly | |
| Raab et al. | Correction of length discrepancies and angular deformities of the leg by Blount's epiphyseal stapling | |
| Li et al. | The Asia proximal femoral nail antirotation versus the standard proximal femoral antirotation nail for unstable intertrochanteric fractures in elderly Chinese patients | |
| Eschler et al. | Intramedullary medial column support with the Midfoot Fusion Bolt (MFB) is not sufficient for osseous healing of arthrodesis in neuroosteoarthropathic feet | |
| Nyquist et al. | Nature and healing of tibial shaft fractures in alcohol abusers | |
| CN106620659A (zh) | 一种有助于骨健康的食品组合物 | |
| Lei et al. | Biomechanical analysis of the fixation systems for anterior column and posterior hemi-transverse acetabular fractures | |
| Ma et al. | Metaphyseal locking plate as an external fixator for open tibial fracture: clinical outcomes and biomechanical assessment | |
| Zhang et al. | Expert consensus on the bone repair strategy for osteoporotic fractures in China | |
| Bajuri et al. | Charcot neuroarthropathy: current surgical management and update. A systematic review | |
| Awad et al. | Indications for hip arthroscopy in pediatric patients a systematic review | |
| Tahami et al. | Practical approach to the native distal femur fractures in the elderly: a rapid review over the recent trends | |
| CN109793219A (zh) | 一种适于老年人群修复关节软骨的营养食品及其制备方法 | |
| Kumar et al. | Less invasive stabilization system for the management of periprosthetic femoral fractures around hip arthroplasty | |
| Ferguson et al. | Tibial bowing in children | |
| Shu et al. | Effect of artificial tiger bone powder (jintiange Capsule®) on vertebral height ratio, cobb's angle, bone mineral density, and visual analog score | |
| Parikh et al. | Functional and radiological outcome of proximal femoral nailing versus dynamic hip screw in unstable intertrochanteric femur fractures | |
| Vittayakittipong et al. | Proximal tibial bone graft: the volume of cancellous bone, and strength of decancellated tibias by the medial approach | |
| Nabi et al. | Fracture patterns resulting from falls from walnut trees in Kashmir | |
| Brock et al. | Post-traumatic periprosthetic tibial and fibular fracture after total ankle arthroplasty: a case report | |
| Singh et al. | Functional outcome of MIPO (Minimally Invasive Plate Osteosynthesis) in distal third femur fractures with intra articular extension | |
| Dorta | Physical Therapy in the pre and post the transtibial amputation | |
| Gatamov et al. | Correction of torsion deformities in adolescents and adults with cerebral palsy, impact on gait parameters | |
| Kim | Factors associated with the bone mineral density in Korean adults: Data from the 2010-2011 Korean National Health and Nutrition Examination Survey (KNHANES) V |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |